Beit Jala Pharmaceutical Co (XPAE:BJP) Interest Coverage: 0 (At Loss) (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beit Jala Pharmaceutical Co Interest Coverage?

Beit Jala Pharmaceutical Co XPAE:BJP Interest Coverage is 0 (At Loss) as of . 20. The stock has 1 warning sign investors should review.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Beit Jala Pharmaceutical Co's Operating Income for the six months ended in . 20 was JOD0.00 Mil. Beit Jala Pharmaceutical Co's Interest Expense for the six months ended in . 20 was JOD0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Beit Jala Pharmaceutical Co's Interest Coverage or its related term are showing as below:


XPAE:BJP's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.125
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beit Jala Pharmaceutical Co  (XPAE:BJP) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Beit Jala Pharmaceutical Co Interest Coverage Related Terms

Beit Jala Pharmaceutical Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Beit Jala Pharmaceutical Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Beit Jala Pharmaceutical Co Interest Coverage Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
Interest Coverage

Beit Jala Pharmaceutical Co Semi-Annual Data
Interest Coverage

XPAE:BJP vs : Interest Coverage Comparison

For the Biotechnology subindustry, Beit Jala Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beit Jala Pharmaceutical Co Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beit Jala Pharmaceutical Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Beit Jala Pharmaceutical Co's Interest Coverage falls into.


Beit Jala Pharmaceutical Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beit Jala Pharmaceutical Co's Interest Coverage for the fiscal year that ended in . 20 is calculated as

Here, for the fiscal year that ended in . 20, Beit Jala Pharmaceutical Co's Interest Expense was JOD0.00 Mil. Its Operating Income was JOD0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was JOD0.00 Mil.

Beit Jala Pharmaceutical Co had no debt (1).

Beit Jala Pharmaceutical Co's Interest Coverage for the quarter that ended in . 20 is calculated as

Here, for the six months ended in . 20, Beit Jala Pharmaceutical Co's Interest Expense was JOD0.00 Mil. Its Operating Income was JOD0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was JOD0.00 Mil.

Beit Jala Pharmaceutical Co had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a Interest Coverage of 0 (At Loss) as of . 20. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Beit Jala Pharmaceutical Co and its competitors.
Is Beit Jala Pharmaceutical Co's Interest Coverage too high?
Beit Jala Pharmaceutical Co's current Interest Coverage is 0 (At Loss).
How does Beit Jala Pharmaceutical Co's Interest Coverage compare to ?
Beit Jala Pharmaceutical Co's Interest Coverage of 0 (At Loss) can be compared against companies in the Biotechnology industry. The industry median Interest Coverage is 106.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.13, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Beit Jala Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beit Jala Pharmaceutical Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beit Jala Pharmaceutical Co stock overvalued right now?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Beit Jala Pharmaceutical Co (XPAE:BJP), the current Interest Coverage is 0 (At Loss) as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beit Jala Pharmaceutical Co Business Description

Comparable Companies
Address 81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.